In a joint effort for accelerating the UAE’s vision for a world-class healthcare system, the Dubai Branch of BD (Becton, Dickinson, and Company), and VPS Healthcare’s Burjeel Medical City (BMC) recently announced a strategic partnership that will empower both firms to accelerate innovation and deliver healthcare excellence in the country.
This partnership between BD and Burjeel Medical City will create valuable opportunities to offer the healthcare provider with cutting-edge MedTech innovations in pursuit of offering improved safety and care for patients and healthcare workers in the UAE. Additionally, to MedTech solutions, this joint effort will enhance safety practices and measures by providing training to enable a better understanding of advanced solutions and safety procedures.
Maher Elhassan, Vice President & General Manager, BD Middle East, North Africa & Turkey stated: “This partnership is a cornerstone of our combined efforts to help advance UAE’s healthcare system. The continued emphasis on patient safety inspires us to invest more into innovative collaborations to deliver safety and care to both patients and healthcare workers, rapid diagnosis, antimicrobial resistance as well as training of medical practitioners. Together, we will advance the world of health and positively impact patient lives.”
John Sunil, CEO, of Burjeel Group, spoke regarding the partnership stating: “As a leading healthcare network in UAE, we understand how laboratories play a vital role in delivering patient care. The Burjeel Medical City’s Central Lab is equipped with total lab automation, allowing us to connect all our sites across the U.A.E. with a capacity of nearly 10 million tests per year.”
John added: “Our collaboration with BD is yet another important step in our pursuit of constantly delivering healthcare excellence and improving patient outcomes. This partnership will enable us to detect emerging antimicrobial resistance, rapidly implement infection control procedures, initiate appropriate antibiotic therapies for treating these infections, and improve patient management. Burjeel Medical City is constantly investing and establishing new partnerships to identify cutting-edge medical technologies and innovations that can help us deliver world-class healthcare to the people of the UAE.”
Industry sources added that the partnership will also explore the latest ways of boosting improvement in rapid diagnosis while reducing errors in the course of treatments. As part of the training, BD and Burjeel Medical City will also work on creating awareness of antimicrobial resistance (AMR) procedures.
BD added that this will lead to curbing the threats of infections and maintaining adequate prevention against prolonged illness, timely and accurate diagnostics, surveillance, and advanced medication management.
